| Dr Keshav Teelucksingh, MD | |
|
2015 Grand Concourse, Bronx, NY 10453-4303 | |
| (718) 299-7295 | |
| (718) 299-6797 |
| Full Name | Dr Keshav Teelucksingh |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 16 Years |
| Location | 2015 Grand Concourse, Bronx, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003164179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 309368 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
| Entity Name | Essen Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366418709 PECOS PAC ID: 1759353501 Enrollment ID: O20040811000885 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
| Entity Name | House Call Medical Services Of New York Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851345946 PECOS PAC ID: 2264517754 Enrollment ID: O20080307000427 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
| Entity Name | Bronx Medical Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356726087 PECOS PAC ID: 9739496100 Enrollment ID: O20150917000004 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
| Entity Name | Shakespeare Operating Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720634538 PECOS PAC ID: 0840604310 Enrollment ID: O20210123000014 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keshav Teelucksingh, MD 1434 Williamsbridge Rd, Bronx, NY 10461-2507 Ph: (718) 618-0401 | Dr Keshav Teelucksingh, MD 2015 Grand Concourse, Bronx, NY 10453-4303 Ph: (718) 299-7295 |
News Archive
Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.
According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.
Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted two United States patents for its total disc replacement (TDR) technology that features the use of silicon nitride in the construction of the complete implant.
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 1 days ago
Selina Sultana Zaman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |